The most therapeutic approach for the treatment of AD are drugs that aim to inhibit enzymes acetylcholineesterase (AChE) and butyrylcholineesterase (BuChE), thereby increasing acetylcholine concentration in cholinergic synaptic clefts (3, 4). This evidence concerns the gene ACHE and Alzheimer disease.